Cite
Eschenbrenner J, Winsel S, Hammer S, et al. Evaluation of activity and combination strategies with the microtubule-targeting drug sagopilone in breast cancer cell lines. Front Oncol. 2011;1:44doi: 10.3389/fonc.2011.00044.
Eschenbrenner, J., Winsel, S., Hammer, S., Sommer, A., Mittelstaedt, K., Drosch, M., Klar, U., Sachse, C., Hannus, M., Seidel, M., Weiss, B., Merz, C., Siemeister, G., & Hoffmann, J. (2011). Evaluation of activity and combination strategies with the microtubule-targeting drug sagopilone in breast cancer cell lines. Frontiers in oncology, 144. https://doi.org/10.3389/fonc.2011.00044
Eschenbrenner, Julia, et al. "Evaluation of activity and combination strategies with the microtubule-targeting drug sagopilone in breast cancer cell lines." Frontiers in oncology vol. 1 (2011): 44. doi: https://doi.org/10.3389/fonc.2011.00044
Eschenbrenner J, Winsel S, Hammer S, Sommer A, Mittelstaedt K, Drosch M, Klar U, Sachse C, Hannus M, Seidel M, Weiss B, Merz C, Siemeister G, Hoffmann J. Evaluation of activity and combination strategies with the microtubule-targeting drug sagopilone in breast cancer cell lines. Front Oncol. 2011 Nov 16;1:44. doi: 10.3389/fonc.2011.00044. eCollection 2011. PMID: 22649765; PMCID: PMC3355879.
Copy
Download .nbib